Mucin 1 as a Molecular Target of a Novel Diisoquinoline Derivative Combined with Anti-MUC1 Antibody in AGS Gastric Cancer Cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mucin 1 as a Molecular Target of a Novel Diisoquinoline Derivative Combined with Anti-MUC1 Antibody in AGS Gastric Cancer Cells
Authors
Keywords
-
Journal
MOLECULES
Volume 26, Issue 21, Pages 6504
Publisher
MDPI AG
Online
2021-10-29
DOI
10.3390/molecules26216504
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel Insights into the Cellular Localization and Regulation of the Autophagosomal Proteins LC3A, LC3B and LC3C
- (2020) Marius W. Baeken et al. Cells
- The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe?
- (2020) Jing-Li Xu et al. Frontiers in Cell and Developmental Biology
- Monoclonal anti‑MUC1 antibody with novel octahydropyrazino[2,1‑a:5,4‑a']diisoquinoline derivative as a potential multi‑targeted strategy in MCF‑7 breast cancer cells
- (2019) Agnieszka Gornowicz et al. ONCOLOGY REPORTS
- Molecular mechanism of Helicobacter�pylori‑induced autophagy in gastric cancer (Review)
- (2019) Fan Zhang et al. Oncology Letters
- Targeting autophagy in cancer
- (2018) Angelique V. Onorati et al. CANCER
- Drug discovery targeting the mTOR pathway
- (2018) Alberto M. Martelli et al. CLINICAL SCIENCE
- The molecular mechanism of anticancer action of novel octahydropyrazino[2,1-a:5,4-a′]diisoquinoline derivatives in human gastric cancer cells
- (2018) Natalia Pawłowska et al. INVESTIGATIONAL NEW DRUGS
- Rottlerin promotes autophagy and apoptosis in gastric cancer cell lines
- (2018) Jun Song et al. Molecular Medicine Reports
- Autophagy and its role in gastric cancer
- (2018) Yijing Cao et al. CLINICA CHIMICA ACTA
- Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician
- (2017) S. Lheureux et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Biological evaluation of octahydropyrazin[2,1-a:5,4-a′]diisoquinoline derivatives as potent anticancer agents
- (2017) Agnieszka Gornowicz et al. TUMOR BIOLOGY
- Biological evaluation of dimethylpyridine–platinum complexes with potent antiproliferative activity
- (2016) Robert Czarnomysy et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- New advances in targeted gastric cancer treatment
- (2016) Daniela Cornelia Lazăr et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Functional role of autophagy in gastric cancer
- (2016) Hao-ran Qian et al. Oncotarget
- Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma
- (2016) Ozgur ILHAN et al. Turkish Journal of Gastroenterology
- Autophagy regulation in the development and treatment of breast cancer
- (2015) Yuting Zhou et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
- (2015) Seiji Mabuchi et al. GYNECOLOGIC ONCOLOGY
- Participation of autophagy in the cytotoxicity against breast cancer cells by cisplatin
- (2015) MENG SHEN et al. ONCOLOGY REPORTS
- Artesunate induces G2/M cell cycle arrest through autophagy induction in breast cancer cells
- (2014) Kai Chen et al. ANTI-CANCER DRUGS
- Cytotoxic activity of octahydropyrazin[2,1-a:5,4-a′]diisoquinoline derivatives in human breast cancer cells
- (2014) Monika Lepiarczyk et al. ARCHIVES OF PHARMACAL RESEARCH
- Essential role for autophagy in the maintenance of immunological memory against influenza infection
- (2014) Min Chen et al. NATURE MEDICINE
- Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation
- (2014) Yvette C. Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tubulin hyperacetylation is adaptive in cardiac proteotoxicity by promoting autophagy
- (2014) Patrick M. McLendon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nilotinib Induces Autophagy in Hepatocellular Carcinoma through AMPK Activation
- (2013) Hui-Chuan Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of a candidate therapeutic autophagy-inducing peptide
- (2013) Sanae Shoji-Kawata et al. NATURE
- Gastric cancer: adding glycosylation to the equation
- (2013) Salomé S. Pinho et al. TRENDS IN MOLECULAR MEDICINE
- Compromised autophagy byMIR30Bbenefits the intracellular survival ofHelicobacter pylori
- (2012) Bin Tang et al. Autophagy
- MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
- (2012) D W Kufe ONCOGENE
- Autophagy: Renovation of Cells and Tissues
- (2011) Noboru Mizushima et al. CELL
- Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
- (2011) R. K. Amaravadi et al. CLINICAL CANCER RESEARCH
- Blocking NF-κB nuclear translocation leads to p53-related autophagy activation and cell apoptosis
- (2011) Bao-Song Zhu WORLD JOURNAL OF GASTROENTEROLOGY
- PI3K/AKT/mTOR Pathway in Angiogenesis
- (2011) Jayashree Karar et al. Frontiers in Molecular Neuroscience
- Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells
- (2010) S Bafna et al. ONCOGENE
- PAC-1 Activates Procaspase-3 in Vitro through Relief of Zinc-Mediated Inhibition
- (2009) Quinn P. Peterson et al. JOURNAL OF MOLECULAR BIOLOGY
- Small-Molecule Activators of a Proenzyme
- (2009) D. W. Wolan et al. SCIENCE
- The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis, but not with postoperative survival.
- (2008) Jolanta Czyzewska et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- A new route to optically pure highly functionalized tetrahydro-isoquinolines with a quaternary carbon stereocenter
- (2008) Zbigniew Kałuża et al. TETRAHEDRON
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started